Alefacept in the treatment of psoriatic nail disease: A small case series

被引：22

作者：

Cassetty, CT

Alexis, AF

Shupack, JL

Strober, BE

机构：

[1] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA

[2] Biogen Idec, Cambridge, MA USA

[3] Genentech Inc, San Francisco, CA 94080 USA

[4] Centocor Inc, Malvern, PA 19355 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2005.01.101

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

收藏

页码：1101 / 1102

页数：2

相关论文

共 3 条

[1] Treatment of psoriatic nails with topical cyclosporin:: A prospective, randomized placebo-controlled study
Cannavò, SP
Guarneri, F
Vaccaro, M
Borgia, F
Guarneri, B
[J]. DERMATOLOGY, 2003, 206 (02) : 153 - 156
[2] A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
Krueger, GG
Papp, KA
Stough, DB
Loven, KH
Gulliver, WP
Ellis, CN
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (06) : 821 - 833
[3] Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis
Rich, P
Scher, RK
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : 206 - 212